10 April 2014 - Deborah Wilkes
Archived
India's Sun Pharmaceutical Industries has agreed to acquire Ranbaxy Laboratories, including its Global Consumer Healthcare division, from Japan's Daiichi Sankyo in an all-share deal worth US$4.0 billion.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.